Delhomme, Nicolas
- German Cancer Research Center
Although the prognosis of most glioblastoma patients is poor, 3%-5% patients show long-term survival of 36 months or longer after diagnosis. To study the differences in activation of biochemical pathways, we performed mRNA and protein expression analyses of primary glioblastoma tissues from 11 long-term survivors (LTS; overall survival >= 36 months) and 12 short-term survivors (STS; overall survival
JNCI: Journal of the National Cancer Institute
2011, volym: 103, nummer: 7, sidor: 598-601
Utgivare: OXFORD UNIV PRESS INC
Genetik och genomik
Bioinformatik och beräkningsbiologi (Metodutveckling under 10203)
https://res.slu.se/id/publ/80798